Houdan, France

Sergio Kreimerman


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Inventor Spotlight: Sergio Kreimerman**

Introduction

Sergio Kreimerman, an inventive mind based in Houdan, France, has made notable contributions to the field of pharmaceuticals. With a total of two patents to his name, Kreimerman has focused on refining processes in medicinal chemistry, particularly related to the compound cinacalcet.

Latest Patents

Kreimerman's recent patent titled "Process for preparing cinacalcet and pharmaceutically acceptable salts thereof" centers around an innovative methodology for synthesizing cinacalcet. The patent outlines a process that involves reacting 3-trifluoromethylbenzaldehyde with a phosphorus-comprising derivative, where both R groups may be identical or different and consist of (C-C)alkyl groups. This invention not only encompasses the synthesis of cinacalcet but also delves into the phosphorus-comprising derivative and its applications, including the phosphate salt of cinacalcet and its uses.

Career Highlights

Throughout his career, Kreimerman has worked with prominent companies, including Produits Chimiques Auxiliaires et de Synthèse. His expertise in pharmaceuticals has contributed to advancements in therapeutic compounds and their production methods.

Collaborations

Kreimerman has collaborated with skilled professionals like Jean-Marie Schneider and Jonathan Madec. These collaborations have enriched his research and enabled the sharing of valuable insights within the pharmaceutical community.

Conclusion

Sergio Kreimerman stands out as a passionate inventor in the field of pharmaceuticals. His recent patents reflect a commitment to advancing drug development processes, particularly concerning cinacalcet and its derivatives. With significant career achievements and collaborations, Kreimerman’s work continues to impact the pharmaceutical landscape positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…